L-lysine alongside normal medication may benefit schizophrenia patients
April 18th, 2011 - 4:40 pm ICT by ANIWashington, April 18 (ANI): A study has shown that patients with schizophrenia who received L-lysine alongside their normal medication found some reduction in the severity of their symptoms.
Schizophrenia is a serious mental disorder. Most patients find some relief from their symptoms by treatment with antipsychotics, however they may still suffer from cognitive and negative symptoms. These include poor concentration and memory, apathy, or a reduced ability to cope in social situations.
In a cross-over study, 10 patients with schizophrenia were given either 6g of L-lysine or a placebo every day for four weeks. Each of the patients had been on a stable dose of medication for the past three months and had been free from psychotic episodes for the two months before the study began.
They were tested for blood levels of lysine as well as the severity of their symptoms (PANSS) and functional ability (including the Wisconsin Card Sorting and Trail Making tests) at the start, after four, and after eight weeks.
Eight of the patients responded to L-lysine treatment, as shown by an increase in blood lysine levels. For these eight there was a general trend, over most of the symptomatic and cognitive tests, for improvement due to treatment with lysine. Three of the patients reported that they themselves felt some improvement.
However there was a tendency for any intervention, L-lysine or placebo, to improve PANSS scores, and familiarity with the tests improved scores for the memory and mental functioning tests. So improvement was seen using both L-lysine and placebo.
Results were probably also confounded by the beneficial effect of L-lysine continuing even after treatment stopped and consequently affecting scores of patients who received placebo after lysine.
“This study is a starting place for further research into the beneficial effects of L-lysine as part of the treatment of patients with schizophrenia. It was an extremely low dose, and a small sized trial, which limited the conclusions we could draw. Nevertheless this study suggests that L-lysine may be of benefit to patients in alleviating some of the negative and cognitive effects of schizophrenia,” said Dr Wass.
The study has been published in BioMed Central’s open access journal BMC Medicine. (ANI)
- More effective schizophrenia cure promised - Apr 18, 2011
- Brain oestrogen shows promise as schizophrenia treatment - May 17, 2010
- Evidence to confirm ginseng's brain boosting ability is weak: Study - Dec 08, 2010
- Antidepressant may help improve cognitive function after stroke - Feb 02, 2010
- Antidepressants could help with stroke recovery - Apr 08, 2011
- Nineteenth century therapy may help Parkinson's patients - Apr 23, 2012
- Yoga effective in treating psychiatric disorders - Sep 20, 2011
- Arthritis protein can reverse memory loss in Alzheimer's - Aug 23, 2010
- Higher dosage of ADHD drug retards learning - Mar 12, 2012
- Cold sore virus could lead to schizophrenia symptoms - May 29, 2010
- Molecule from shark cartilage fights joint pain - Sep 18, 2011
- Antibiotics alleviate symptoms of schizophrenia - Mar 03, 2012
- Exercise good for schizophrenics' brains - Feb 02, 2010
- Cold sore virus likely to cause brain abnormalities - Jun 01, 2010
- Ritalin boon for people who commit mistakes - Feb 28, 2012
Tags: 6g, antipsychotics, apathy, beneficial effect, beneficial effects, blood levels, card sorting, cognitive tests, extre, familiarity, functional ability, further research, l lysine, lysine, mental disorder, poor concentration, psychotic episodes, schizophrenia, schizophrenia patients, social situations